Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

NCT00050817 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
15603
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi